IL17A and colorectal carcinoma: Mechanistic studies in colitis-associated cancer (CAC) and APCmin/+ CRC models revealed that PD-L1 levels were upregulated by IL-17A and miR-15b-5p at the post-transcriptional level, thereby suppressing the efficacy of ICIs.